Physician profile
William E Scherger
NPI 1689677536
$520.97
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $136 · 2021: $175.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $181.97 | 2019-2021 | |
| Daiichi Sankyo INC. | $78.67 | 2019-2021 | |
| Astellas Pharma US INC | $64.11 | 2019-2020 | |
| Pfizer INC. | $63.29 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $37.71 | 2020-2021 | |
| Exeltis, USA INC. | $16.57 | 2020 | |
| Minerva Surgical, INC | $14.99 | 2021 | |
| Therapeuticsmd, INC. | $14.83 | 2021 | |
| Hologic Sales and Service, LLC | $14.63 | 2021 | |
| Avanos Medical | $11.72 | 2019 | |
| Allergan, INC. | $11.39 | 2020 | |
| Merck Sharp & Dohme LLC | $11.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Scherger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.